✦ LIBER ✦

Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone

✍ Scribed by Tiina Jaakkola; Janne T. Backman; Mikko Neuvonen; Mikko Niemi; Pertti J. Neuvonen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The CYP2C8 inhibitor gemfibrozil does no

✍ Tiina Karonen; Pertti J. Neuvonen; Janne T. Backman 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 141 KB

Pioglitazone, an in vitro inhibitor of C

✍ Lauri I. Kajosaari; Tiina Jaakkola; Pertti J. Neuvonen; Janne T. Backman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 164 KB

The pharmacokinetics of ketobemidone are

✍ Ayman Al-Shurbaji; Juliette Säwe 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 84 KB

CYP2C9*3and*13alleles significantly affe

✍ Chang-Ik Choi; Mi-Jeong Kim; Eun-Kyung Chung; Hye-In Lee; Choon-Gon Jang; Jung-W 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 157 KB

Influence of CYP2C19 genotype on the pha

✍ Katrijn Bogman; Mariabeth Silkey; Siew Pheng Chan; Brian Tomlinson; Cornelia Web 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 216 KB

Irbesartan does not affect the steady-st

✍ B. Mangold; W. Gielsdorf; M. R. Marino 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 96 KB